BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9522325)

  • 21. Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel.
    Paoletti AM; Pilloni M; Orrù M; Floris S; Pistis M; Guerriero S; Ajossa S; Melis GB
    Maturitas; 2002 Jun; 42(2):137-47. PubMed ID: 12065173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined oestrogen-progestin replacement therapy prevents atherosclerosis in postmenopausal women.
    Punnonen RH; Jokela HA; Dastidar PS; Nevala M; Laippala PJ
    Maturitas; 1995 Apr; 21(3):179-87. PubMed ID: 7616866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.
    Boerrigter PJ; van de Weijer PH; Baak JP; Fox H; Haspels AA; Kenemans P
    Maturitas; 1996 May; 24(1-2):63-71. PubMed ID: 8794436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
    Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
    Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
    Marslew U; Overgaard K; Riis BJ; Christiansen C
    Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device.
    Raudaskoski TH; Tomás EI; Paakkari IA; Kauppila AJ; Laatikainen TJ
    Maturitas; 1995 Jun; 22(1):47-53. PubMed ID: 7666816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of two hormone replacement therapy regimens on safety and efficacy variables.
    Siseles NO; Halperin H; Benencia HJ; Berg G; Pilnik S; Mesch V; Arrighi B; Wikinski RW
    Maturitas; 1995 Apr; 21(3):201-10. PubMed ID: 7616869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
    Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
    Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
    Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.
    Hänggi W; Lippuner K; Riesen W; Jaeger P; Birkhäuser MH
    Br J Obstet Gynaecol; 1997 Jun; 104(6):708-17. PubMed ID: 9197875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of transdermal oestrogen therapy in postmenopausal women: a comparative study of an oestradiol gel and an oestradiol delivering patch.
    Hirvonen E; Cacciatore B; Wahlström T; Rita H; Wilén-Rosenqvist G
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():26-31. PubMed ID: 9389780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The acceptability of a small intrauterine progestogen-releasing system for continuous combined hormone therapy in early postmenopausal women.
    Sturdee DW; Rantala ML; Colau JC; Zahradnik HP; Riphagen FE;
    Climacteric; 2004 Dec; 7(4):404-11. PubMed ID: 15799612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women.
    Stomati M; Bersi C; Rubino S; Palumbo M; Comitini G; Genazzani AD; Santuz M; Petraglia F; Genazzani AR
    Maturitas; 1997 Dec; 28(2):127-35. PubMed ID: 9522320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 2-year study on the beneficial effects of 17 beta-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: no additional unfavourable effects of dydrogesterone.
    van der Mooren MJ; Demacker PN; Thomas CM; Borm GF; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1993 Dec; 52(2):117-23. PubMed ID: 8157140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of the hormone replacement drug estradiol valerate/levonorgestrel in the treatment of menopausal syndrome in Thai women.
    Chittacharoen A; Domhardt R; Manonai J; Golbs S
    Methods Find Exp Clin Pharmacol; 2003 Oct; 25(8):645-51. PubMed ID: 14671683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
    Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT
    Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing continuous-combined hormone replacement therapy for postmenopausal women: a comparison of six different treatment regimens.
    Heikkinen JE; Vaheri RT; Ahomäki SM; Kainulainen PM; Viitanen AT; Timonen UM
    Am J Obstet Gynecol; 2000 Mar; 182(3):560-7. PubMed ID: 10739508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
    J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.